Search Results
266 items found for "cell-cell communication"
- Ep 147 with Dr. Demet Araç
Axel Brunger’s lab at Stanford University to study the structure and function of cell-adhesion proteins
- Ep 128 with Dr. Ilana Kotliar
study the regulation and protein-protein interactions of GPCRs and a small family of accessory proteins called Outside of the lab, Ilana is a leader within her community, spearheading several outreach initiatives
- Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors
Here we used a dataset of mutations found in patient samples derived from the Genomic Data Commons and Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR
- Ep 27 with Dr. Robert J. Lefkowitz
Well, it’s the one and only Robert J. Before we pressed record, I asked if I could call him Bob, and he answered that only his mom used to call him Robert, especially when she was upset with him. I very much enjoyed chatting with Bob, and I hope you’ll enjoy learning more about him as well. Dr.
- Neutrophils are itching to specialize
Bryan G Yipp Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Ep 81 with Dr. Christel Menet
I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
Univariant and multivariant Cox regression analyses, as well as least absolute shrinkage and selection Sensitivity to immunotherapy and common antitumor drugs was predicted via the database Genomics of Drug treatment Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Ep 19 with Dr. Fiona Marshall
As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery
- Content Guidelines | Dr. GPCR Ecosystem
Try to tell your own story without resorting to broad generalizations and conclusory allegations. Don't tell the same old story you've already told. Guidelines A post is a place for fun, open, and honest conversations about what's going on in your community A dash of common sense goes a long way. And since user trust and transparency are important to us, anonymous users who are disruptive to the community
- About Us | Dr. GPCR Ecosystem
GPCR Ecosystem We bring the GPCR community to fuel GPCR drug discovery one receptor at a time. About Us: About Us Founded in 2020, we decided to bring together the GPCR community and break down any To join the community you must be related to the GPCR field. Once in the Dr.
- Ep 116 with Dr. Shivani Sachdev
She is also very active within the pharmacology community and currently serves on the editorial board Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable
- Home | Dr. GPCR Ecosystem
We aspire to provide opportunities to connect, grow, and thrive as a great GPCR Community.
- Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil chemoattractant
proteoglycan Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
In conclusion, chemokine N-termini can be mimicked to produce small CCR1-selective agonists, as well pharmacology Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency
SCI leads to severe secondary immunosuppression, called SCI-induced immunodeficiency syndrome (SCI-IDS Methods and objectives: The concentrations of adrenocorticotropic hormone and cortisol in plasma, as well Transcriptome Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Retreat | Dr. GPCR Ecosystem
Click the button to unlock premium content, and insights and join our vibrant community of like-minded into the GPCR World Valid for 12 months + 5 day free trial Select Thank you for being a part of our community
- Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers
Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR
- Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
Hervé Lefebvre Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery
A GPCR activation process based on the well-discerned conformational states is thus proposed, allosterically micro-modulated by the cation-π lock and a previously well-defined ionic interaction between TM3 and , Libin Ye Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Summit | Dr. GPCR Ecosystem
Our goal is to allow everyone in the GPCR community to get access to the talks through the entire length
- Dr. GPCR Ecosystem
We aspire to provide opportunities to connect, grow, and thrive as a great GPCR Community.
- Deciphering the genetic landscape of lumpy skin disease: Unraveling variable virulence through comprehensive genome sequence analysis in India
Virulence Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- A GPCR-neuropeptide axis dampens hyperactive neutrophils by promoting an alternative-like polarization during bacterial infection
Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR
- GPCRs and fibroblast heterogeneity in fibroblast-associated diseases
targeting Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome
intolerance , POTS Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- From odor to oncology: non-canonical odorant receptors in cancer
emerging evidence suggests a compelling interplay between odorant receptors and cancer progression as well Namgyu Lee Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Roland B Walter Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call
- Newsletter for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
We welcome suggestions, feedback, and announcements from the community....